Cargando…
Targeted nonviral gene therapy in prostate cancer
Prostate cancer is the second-most widespread cancer in men worldwide. Treatment choices are limited to prostatectomy, hormonal therapy, and radiotherapy, which commonly have deleterious side effects and vary in their efficacy, depending on the stage of the disease. Among novel experimental strategi...
Autores principales: | Altwaijry, Najla, Somani, Sukrut, Dufès, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165780/ https://www.ncbi.nlm.nih.gov/pubmed/30310278 http://dx.doi.org/10.2147/IJN.S139080 |
Ejemplares similares
-
PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells
por: Somani, Sukrut, et al.
Publicado: (2018) -
Transferrin‐bearing liposomes entrapping plumbagin for targeted cancer therapy
por: Sakpakdeejaroen, Intouch, et al.
Publicado: (2019) -
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12
por: Altwaijry, Najla, et al.
Publicado: (2018) -
Lactoferrin-Bearing Gold Nanocages for Gene Delivery in Prostate Cancer Cells in vitro
por: Almowalad, Jamal, et al.
Publicado: (2021) -
Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer Cells
por: Almowalad, Jamal, et al.
Publicado: (2022)